Peter Brenneisen

Title: Innovations of Peter Brenneisen in Nanoparticle Technology.

Introduction

Peter Brenneisen is a notable inventor based in Dusseldorf, Germany. He has made significant contributions to the field of nanoparticle technology, particularly through his innovative work on cerium oxide nanoparticles. His research focuses on the applications of these nanoparticles in medical treatments, showcasing their potential in combating tumor invasiveness.

Latest Patents

Brenneisen holds a patent for "Redox active cerium oxide nanoparticles and associated methods." This invention describes nanoparticles that consist of a dextran-coated crystalline structure of cerium oxide. The unique feature of these nanoparticles is that tetravalent Ce predominates over trivalent Ce, and they have a diameter ranging from approximately 3 to 5 nm. These nanoparticles exhibit both superoxide dismutase activity and catalase activity in environments with a substantially neutral or acidic pH. They can be utilized in medications aimed at promoting a cytotoxic anti-invasive effect on squamous tumor cells, thereby inhibiting tumor invasiveness.

Career Highlights

Brenneisen is affiliated with the University of Central Florida Research Foundation, Inc., where he continues to advance his research in nanoparticle applications. His work has garnered attention for its potential impact on cancer treatment and therapeutic strategies.

Collaborations

Throughout his career, Brenneisen has collaborated with esteemed colleagues such as Sudipta Seal and Ajay Karakoti. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field of nanotechnology.

Conclusion

Peter Brenneisen's contributions to nanoparticle technology exemplify the intersection of innovation and medical application. His patented work on cerium oxide nanoparticles holds promise for future advancements in cancer treatment.